Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047515 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00047515: Completed Phase 3 study, sponsored by Alcon Research.
NCT00047515 is a Phase 3 study that has completed, run by Alcon Research. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00047515, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
Interventions
- DRUG Alcon Investigational Agent
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2003-12 |
| Phase | Phase 3 |
What the finished NCT00047515 record still lists
NCT00047515 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Alcon Investigational Agent is the first listed.
NCT00047515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00047515 about?
NCT00047515 is a clinical study titled "Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69". To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
What is the current status of trial NCT00047515?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-01. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00047515?
The interventions under investigation include: Alcon Investigational Agent (DRUG).
Who is sponsoring clinical trial NCT00047515?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia